Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration [NA]
A clinical trial evaluates repeated low-level red-light therapy for dry age-related macular degeneration, with status not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration [NA]
This document describes a post-market clinical investigation of the SING IMT System (Model NG SI IMT 3X) for end-stage age-related macular d…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Factors in Learning And Plasticity: Healthy Vision [NA]
This clinical trial update describes a study of factors in learning and plasticity related to vision. It involves conditions such as central…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Factors in Learning And Plasticity: Macular Degeneration [NA]
A University of Alabama at Birmingham study on learning and plasticity in macular degeneration is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses [Phase 1]
A Phase 1 clinical trial update for ABF-101 in single- and multiple-ascending dose cohorts is underway. The study targets age-related macula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD [Phase 2]
This document reports that GAL-101, a 2% ophthalmic solution developed by Galimedix Therapeutics, is being evaluated in a Phase 2 trial for …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Mirabegron in Patients With Age-Related Macular Degeneration
A clinical trial is investigating mirabegron in patients with age-related macular degeneration (specifically dry AMD) and overactive bladder…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 1, Phase 2]
An early-stage clinical trial is evaluating autologous induced pluripotent stem cell-derived retinal pigment epithelium transplantation for …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium [EARLY_Phase 1]
Phase 1 feasibility and safety trial evaluating MB-102 for ocular angiography versus fluorescein sodium is currently recruiting. The study t…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). [Phase 3]
A Phase 3 clinical trial (TIGER) evaluating vitrectomy with subretinal tissue plasminogen activator and intravitreal gas for submacular hemo…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: COVID-19 Related Lockdown Effects On Chronic Diseases
This clinical trial update reports on the effects of COVID-19 lockdown on the management of several chronic diseases. The study encompasses …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]
Phase 2 trial update of BI 771716 for geographic atrophy, a form of age-related macular degeneration, currently active_not_recruiting.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD [Phase 2]
This Phase 2 clinical trial investigates whether dark adaptation can serve as an early indicator of response to statin therapy in intermedia…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating intravitreal BS01 for geographic atrophy secondary to dry age-related macu…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Learning Study: Improving Vision in Adults With Macular Degeneration [NA]
This clinical trial update indicates a study named Learning Study: Improving Vision in Adults With Macular Degeneration is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: High Resolution Imaging OCT Study [NA]
A high-resolution optical coherence tomography (OCT) imaging trial sponsored by Heidelberg Engineering GmbH is exploring imaging in normal e…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems
Tan Tock Seng Hospital is conducting a user-centric study to assess patients' receptiveness to a web-based automated gaze-tracking analysis …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration [Phase 1]
Phase 1 study to evaluate the safety and tolerability of ASP7317 in senior adults with geographic atrophy secondary to dry age-related macul…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: An Assistant Model for Anti-VEGF Therapy Decision [NA]
This document reports a clinical trial update about an assistant model designed to aid decision-making for anti-VEGF therapy in retinal dise…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration
VA Office of Research and Development is sponsoring a clinical trial aimed at rehabilitating vision loss in veterans with age-related macula…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients
A clinical trial update on automated vision assessment and impairment detection using gaze analysis in patients with age-related macular deg…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking
A completed clinical investigation called CRYSTALSIGHT Cohort 1.5 evaluates remote home monitoring of maculopathy using OCCUTRACK and AI eye…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Non-invasive Ultrasound Retinal Stimulation for Vision Restoration [NA]
A USC-led clinical trial is evaluating non-invasive ultrasound retinal stimulation as a potential vision-restoration therapy for Age-Related…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Eggs and Age-related Macular Degeneration (EggsAMD) Study. [EARLY_Phase 1]
An early-phase 1 clinical trial named EggsAMD is currently recruiting participants to investigate treatment for intermediate age-related mac…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: The Impact of Two Strategies in the Monitoring of Exudative ARMD on the Visual Acuity (by OCT B Scan or OCT Angiography) [NA]
A completed clinical trial comparing OCT B-scan and OCT angiography as monitoring strategies for exudative age-related macular degeneration …